Japanese Biotechs Promote "Relationship Building" In Developing Marketing Deals
This article was originally published in PharmAsia News
Executive Summary
Building solid relationships with licensing partners is key to sustaining and expanding those alliances in the long term, Eisai VP-Business Development Alex Scott said during a May 8 panel discussion at the Biotechnology Industry Organization International Convention in Boston